Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00499382 · ClinicalTrials.gov registry record
Quantitation of Left Ventricular Ejection Fraction as Part of F-18 FDG Whole Body PET/CT Scans For Tumor Staging
A clinical trial, sponsored by M.D. Anderson Cancer Center.
- Terminated
- Registry status
- 5
- Enrollment target
NCT00499382: Clinical Trial study, sponsored by M.D. Anderson Cancer Center.
NCT00499382 is a clinical trial that was terminated before completion, run by M.D. Anderson Cancer Center. The registered enrollment target is 5 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00499382 was terminated before completion, sponsored by M.D. Anderson Cancer Center.
- TERMINATED
- Registry status
- 5 participants
- Enrollment target
Study Summary
Primary Objective: * Evaluate the agreement between radionuclide ventriculography (RNV) and gated F-18 fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) in calculating left ventricular ejection fraction (LVEF), end diastolic volume (EDV) and end systolic volume (ESV).
Interventions
- PROCEDURE Nuclear Medicine Cardiac Scan
- PROCEDURE PET/CT Cardiac Scan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2004-09 |
| Est. Completion | 2009-03 |
Why NCT00499382 stopped before completion
NCT00499382 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 5 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Nuclear Medicine Cardiac Scan is the first listed.
NCT00499382 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00499382 about?
NCT00499382 is a clinical study titled "Quantitation of Left Ventricular Ejection Fraction as Part of F-18 FDG Whole Body PET/CT Scans For Tumor Staging". Primary Objective: * Evaluate the agreement between radionuclide ventriculography (RNV) and gated F-18 fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) in calculating left ventricular ejection fraction (LVEF), end diastolic volume (EDV) and end systolic volume (ESV).
What is the current status of trial NCT00499382?
This trial is currently terminated. The enrollment target is 5 participants. The study started on 2004-09. Estimated completion is 2009-03.
What interventions are being tested in trial NCT00499382?
The interventions under investigation include: Nuclear Medicine Cardiac Scan (PROCEDURE), PET/CT Cardiac Scan (PROCEDURE).
Who is sponsoring clinical trial NCT00499382?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia